168 related articles for article (PubMed ID: 35749951)
21. Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.
Salaroglio IC; Kopecka J; Napoli F; Pradotto M; Maletta F; Costardi L; Gagliasso M; Milosevic V; Ananthanarayanan P; Bironzo P; Tabbò F; Cartia CF; Passone E; Comunanza V; Ardissone F; Ruffini E; Bussolino F; Righi L; Novello S; Di Maio M; Papotti M; Scagliotti GV; Riganti C
J Thorac Oncol; 2019 Aug; 14(8):1458-1471. PubMed ID: 31078776
[TBL] [Abstract][Full Text] [Related]
22. D2-40: a reliable marker in the diagnosis of pleural mesothelioma.
Müller AM; Franke FE; Müller KM
Pathobiology; 2006; 73(1):50-4. PubMed ID: 16785767
[TBL] [Abstract][Full Text] [Related]
23. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
Cheng YY; Kirschner MB; Cheng NC; Gattani S; Klebe S; Edelman JJ; Vallely MP; McCaughan BC; Jin HC; van Zandwijk N; Reid G
J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
[TBL] [Abstract][Full Text] [Related]
24. [Clinical Pathological Diagnosis, and Treatment for Pleural Mesothelioma].
Kishimoto T; Fujimoto N; Nishi H
Gan To Kagaku Ryoho; 2016 May; 43(5):513-7. PubMed ID: 27210080
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
Laszlo V; Hoda MA; Garay T; Pirker C; Ghanim B; Klikovits T; Dong YW; Rozsas A; Kenessey I; Szirtes I; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zöchbauer-Müller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Dome B; Hegedus B
J Pathol; 2015 Oct; 237(2):203-14. PubMed ID: 26011651
[TBL] [Abstract][Full Text] [Related]
26. The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretının.
Sahin N; Akatli AN; Celik MR; Ulutas H; Samdanci ET; Colak C
Pathol Oncol Res; 2017 Jul; 23(3):487-491. PubMed ID: 27761727
[TBL] [Abstract][Full Text] [Related]
27. Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
Nakajima Y; Kuribayashi K; Ishigaki H; Tada A; Negi Y; Minami T; Takahashi R; Doi H; Kitajima K; Yokoi T; Kijima T
Cancer Invest; 2020 Jul; 38(6):356-364. PubMed ID: 32468861
[TBL] [Abstract][Full Text] [Related]
28. Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
Bruno R; Alì G; Giannini R; Proietti A; Lucchi M; Chella A; Melfi F; Mussi A; Fontanini G
Oncotarget; 2017 Jan; 8(2):2758-2770. PubMed ID: 27835874
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
Jurmeister P; Schöler A; Arnold A; Klauschen F; Lenze D; Hummel M; Schweizer L; Bläker H; Pfitzner BM; Mamlouk S; Sers C; Denkert C; Stichel D; Frost N; Horst D; von Laffert M; Capper D
Mod Pathol; 2019 Jun; 32(6):855-865. PubMed ID: 30723296
[TBL] [Abstract][Full Text] [Related]
30. Nucleolin and nucleophosmin expression patterns in pulmonary adenocarcinoma invading the pleura and in pleural malignant mesothelioma.
Masiuk M; Waloszczyk P; Lewandowska M; Dobak E; Urasinska E
Thorac Cancer; 2020 Sep; 11(9):2529-2535. PubMed ID: 32671956
[TBL] [Abstract][Full Text] [Related]
31. [Chronic pleuropathy due to asbestos and malignant mesothelioma of the pleura: a differential diagnosis not always easy. A case report].
de Pangher Manzini V
Recenti Prog Med; 1999 Jun; 90(6):331-3. PubMed ID: 10399473
[TBL] [Abstract][Full Text] [Related]
32. Malignant mesothelioma with squamous differentiation.
Tanaka H; Akiyama Y; Kitamura A; Matsumoto N; Tomita M; Kataoka H
Histopathology; 2018 Jun; 72(7):1216-1220. PubMed ID: 29430704
[TBL] [Abstract][Full Text] [Related]
33. [Morphological diagnostics of malignant pleural mesothelioma].
Junker K; Müller KM
Pathologe; 2014 Nov; 35(6):586-90. PubMed ID: 25304423
[TBL] [Abstract][Full Text] [Related]
34. Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.
Jurmeister P; Bockmayr M; Seegerer P; Bockmayr T; Treue D; Montavon G; Vollbrecht C; Arnold A; Teichmann D; Bressem K; Schüller U; von Laffert M; Müller KR; Capper D; Klauschen F
Sci Transl Med; 2019 Sep; 11(509):. PubMed ID: 31511427
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
Yamada S; Tabata C; Tabata R; Fukuoka K; Nakano T
Clin Chem Lab Med; 2011 Oct; 49(10):1721-6. PubMed ID: 21692685
[TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis of pleural mesothelioma using Logic Learning Machine.
Parodi S; Filiberti R; Marroni P; Libener R; Ivaldi GP; Mussap M; Ferrari E; Manneschi C; Montani E; Muselli M
BMC Bioinformatics; 2015; 16 Suppl 9(Suppl 9):S3. PubMed ID: 26051106
[TBL] [Abstract][Full Text] [Related]
37. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung.
Tsou JA; Shen LY; Siegmund KD; Long TI; Laird PW; Seneviratne CK; Koss MN; Pass HI; Hagen JA; Laird-Offringa IA
Lung Cancer; 2005 Feb; 47(2):193-204. PubMed ID: 15639718
[TBL] [Abstract][Full Text] [Related]
38. Expression of thrombomodulin, calretinin, cytokeratin 5/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma.
Comin CE; Novelli L; Cavazza A; Rotellini M; Cianchi F; Messerini L
Tumori; 2014; 100(5):559-67. PubMed ID: 25343553
[TBL] [Abstract][Full Text] [Related]
39. The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
Marchevsky AM; LeStang N; Hiroshima K; Pelosi G; Attanoos R; Churg A; Chirieac L; Dacic S; Husain A; Khoor A; Klebe S; Lantuejoul S; Roggli V; Vignaud JM; Weynard B; Sauter J; Henderson D; Nabeshima K; Galateau-Salle F
Hum Pathol; 2017 Sep; 67():160-168. PubMed ID: 28782639
[TBL] [Abstract][Full Text] [Related]
40. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]